Standard Biotools (LAB) Net Margin (2010 - 2026)
Standard Biotools (LAB) posted quarterly Net Margin of 670.07% for Q1 2026, up 68324.0% year-over-year from N/an in Q1 2025, and up 7451.05% quarter-over-quarter from 9.12% in Q4 2025.
Standard Biotools (LAB) Net Margin (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Net Margin for 17 consecutive years, with 670.07% the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Margin rose 68324.0% year-over-year to 670.07%; the TTM figure through Mar 2026 stood at 101.06% (up 14141.0% YoY), while the FY2025 annual figure was 87.77%, up 6271.0% from the prior year.
- Net Margin rose to 670.07% in Q1 2026 per LAB's latest filing, from 9.12% in the prior quarter.
- Across five years, Net Margin topped out at 670.07% in Q1 2026 and bottomed at 338.46% in Q2 2022.
- Historically, Net Margin has averaged 10.2% across 5 years, with a median of 70.55% in 2024.
- Annual changes were most pronounced in 2023 — Net Margin sank 51684 bps — and 2026, when it soared 68324 bps.
- Standard Biotools' Net Margin stood at 566.95% in 2022, then plunged by 91 bps to 50.11% in 2023, then grew by 12 bps to 56.0% in 2024, then slumped by 116 bps to 9.12% in 2025, then surged by 7451 bps to 670.07% in 2026.
- Business Quant data shows LAB's Net Margin at 670.07% in Q1 2026, 9.12% in Q4 2025, and 177.41% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.34 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 127.40 Bn | 123.93 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 73.24 Bn | 72.71 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.70 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.39 Bn | 32.44 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 33.87 Bn | 31.76 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.34 Bn | 23.02 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 13.47% |
| 10 | Standard Biotools | 253.41 Mn | -223.31 Mn | 10.54 Mn | -133.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.03% |
| Mar 31, 2026 | 670.07% |
| Dec 31, 2025 | -9.12% |
| Sep 30, 2025 | -177.41% |
| Jun 30, 2025 | -81.21% |
| Mar 31, 2025 | -13.17% |
| Dec 31, 2024 | 56.00% |
| Sep 30, 2024 | -99.24% |
| Jun 30, 2024 | -113.12% |
| Mar 31, 2024 | -70.55% |
| Dec 31, 2023 | 50.11% |
| Sep 30, 2023 | -82.97% |
| Jun 30, 2023 | -61.59% |
| Mar 31, 2023 | -67.05% |
| Dec 31, 2022 | 566.95% |
| Sep 30, 2022 | -114.74% |
| Jun 30, 2022 | -338.46% |
| Mar 31, 2022 | -287.84% |
| Sep 30, 2021 | -53.96% |
| Jun 30, 2021 | -56.34% |